Rock Springs Capital Management LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.5 Billion distributed in 93 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $105M, Eli Lilly & CO with a value of $80.4M, Rhythm Pharmaceuticals, Inc. with a value of $72.4M, Madrigal Pharmaceuticals, Inc. with a value of $63.2M, and Revolution Medicines, Inc. with a value of $62.4M.

Examining the 13F form we can see an increase of $22.8M in the current position value, from $1.47B to 1.5B.

Rock Springs Capital Management LP is based out at Baltimore, MD

Below you can find more details about Rock Springs Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $1.5 Billion
Healthcare: $1.48 Billion
ETFs: $15.2 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 93
  • Current Value $1.5 Billion
  • Prior Value $1.47 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 9 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 35 stocks
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.